We are developing multiplexed, accurate, quantitative and accessible diagnostic tests for cancer and covid.
CANCER
DIAGNOSTICS
COVID-19
DIAGNOSTICS

Featured Projects & Products

News

MORE NEWS

R&D Projects

MultiplexDX Became a Proud Holder of the EIC Accelerator

We are deligted to announce that our company, was selected as one of 75 companies, in a competition of 1,852 projects from all over Europe, to win a prestigious EIC Accelerator grant. Therefore, we became the first Slovak company in history to be awarded an EIC Accelerator by the European Innovation Council (EIC) in the full amount of 3 million EUR, of which MultiplexDX will provide a half million EUR from its own resources.

READ MORE
More R&D projects

Clients

Dr. Hasan Vatandaslar
ETH Zurich

"The MultiplexDX 3'-adapters worked well in PAR-CLIP experiments to barcode and sequence different samples in the same lane. I would recommend these adapters to everyone that is going to perform the same kind of experiment."

Dr. Iddo  Ben-Dov
Hadassah
Hebrew University Medical Center

"We have used - and continue using - custom made MultiplexDX 3'-adapters routinely for our small RNA library preparations - never fail."

Dr. Hani Najafi
Weill Cornell Medicine

"Mulitplex 3’-adapters have been very useful generating barcoded microRNA libraries from a large number of samples and extremely reliable in terms of their stability and compatibility with RNA ligation experiments. We have optimized protocols developed based on those adaptors and it is extremely likely to continue using them in future."

More CLIENTS

Achievements

SHOW ALL ACHIEVEMENTS